Mitsubishi UFJ Trust & Banking
NKTR icon

Mitsubishi UFJ Trust & Banking’s Nektar Therapeutics NKTR Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-895
Closed -$238K – 1394
2021
Q2 		$238K Sell
895
-56
-6% -$15.5K ﹤0.01% 1238
2021
Q1 		$243K Buy
951
+204
+27% +$63.5K ﹤0.01% 1179
2020
Q4 		$190K Buy
747
+560
+299% +$145K ﹤0.01% 1254
2020
Q3 		$46K Buy
+187
New +$58.8K ﹤0.01% 1306
2020
Q1 		– Sell
-12
Closed -$4K – 1320
2019
Q4 		$4K Sell
12
-8,937
-100% -$2.59M ﹤0.01% 1318
2019
Q3 		$2.44M Sell
8,949
-382
-4% -$140K 0.01% 803
2019
Q2 		$4.98M Buy
9,331
+72
+0.8% +$36.1K 0.02% 662
2019
Q1 		$4.67M Buy
9,259
+36
+0.4% +$21.3K 0.02% 649
2018
Q4 		$4.55M Buy
9,223
+721
+8% +$435K 0.02% 634
2018
Q3 		$7.77M Sell
8,502
-13,191
-61% -$11.3M 0.03% 566
2018
Q2 		$15.9M Buy
+21,693
New +$25M 0.03% 605

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's NKTR Position: Q3 2021 in Review

Mitsubishi UFJ Trust & Banking sold out of Nektar Therapeutics (NKTR) in Q3 2021, closing a stake of 895 shares — an estimated $238K sold.

Mitsubishi UFJ Trust & Banking first reported a position in NKTR in Q2 2018 and held it in 11 quarters. The position peaked at $15.9M in Q2 2018. 240 funds tracked by Wall St. Rank hold NKTR as of Q3 2021.

  • Mitsubishi UFJ Trust & Banking reported no remaining Nektar Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Mitsubishi UFJ Trust & Banking sold 895 Nektar Therapeutics shares in Q3 2021, an estimated $238K.
  • Mitsubishi UFJ Trust & Banking first reported a position in Nektar Therapeutics in Q2 2018 and held it in 11 quarters.
  • Mitsubishi UFJ Trust & Banking's Nektar Therapeutics position peaked at $15.9M in Q2 2018.
  • 240 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2021.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q3 2021, filed 12 Nov 2021.